567 results on '"Nelson, Colleen C."'
Search Results
2. Gene expression based inference of cancer drug sensitivity
3. Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation
4. Apocryphal FADS2 activity promotes fatty acid diversification in cancer
5. Valine Catabolism Drives Bioenergetic and Lipogenic Fuel Plasticity in Prostate Cancer
6. Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer.
7. Transcriptomic analysis of mRNA expression and alternative splicing during mouse sex determination
8. Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys3]-GHRP-6
9. A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
10. Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts
11. Disruption of Androgen Regulation in the Prostate by the Environmental Contaminant Hexachlorobenzene
12. Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer
13. Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
14. Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer
15. Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
16. Supplementary Video S1.Time-lapse microscopy of HeLa-H2B-GFP cells treated with DMSO, vinblastine (20 nM) or 6-AA (0.62 nM). from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
17. Supplementary Video S4. Interphase microtubule dynamics in HeLa-EB1-GFP treated with 6-AA (2.5 nM). from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
18. Supplementary Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis
19. Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis
20. Supplemental Files from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis
21. Supplementary Figures 1-3 from Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer
22. Data from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
23. Supplementary Data from Clusterin Facilitates COMMD1 and I-κB Degradation to Enhance NF-κB Activity in Prostate Cancer Cells
24. Data from Clusterin Facilitates COMMD1 and I-κB Degradation to Enhance NF-κB Activity in Prostate Cancer Cells
25. Supplementary Information from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
26. Supplementary Video S2.Time-lapse microscopy of HeLa-H2B-GFP cells treated with 6-AA (2.5, 5 and 10 nM). from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
27. Supplementary Video S3. Interphase microtubule dynamics in HeLa-EB1-GFP treated with DMSO. from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
28. Supplementary Video S5. Interphase microtubule dynamics in HeLa-EB1-GFP treated with vinblastine (20 nM). from 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells
29. Data from Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer
30. Supplementary Tables S1-S2 from In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
31. Data from Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
32. Supplementary Methods, Figure Legends 1-6 from Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression
33. Data from Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells
34. Supplementary Tables 1-2 from Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
35. Supplementary Figures 1-3 from Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells
36. Supplementary Table 3 from Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
37. Supplementary Table Legends 1-2 from Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
38. Data from Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression
39. Supplementary Figures 1-6, Table 1 from Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression
40. hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer
41. Toward Revealing the Complexity of Androgen-Responsive Protein and Noncoding Transcripts in Prostate Cancer
42. Pseudo-grading of tumor subclones using phenotype algebra
43. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis
44. Differential Regulation of Clusterin Isoforms by the Androgen Receptor
45. Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours
46. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer
47. Correction: A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
48. Additional file 1 of Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation
49. Isomeric lipid signatures reveal compartmentalised fatty acid metabolism in cancer
50. Leptin receptor antagonist, Allo-Aca, prevents migration, invasion and modifies lipogenesis pathways in prostate cells: 146
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.